MX2022010079A - Metodos para preparar derivados quirales de benzodiazepinona. - Google Patents

Metodos para preparar derivados quirales de benzodiazepinona.

Info

Publication number
MX2022010079A
MX2022010079A MX2022010079A MX2022010079A MX2022010079A MX 2022010079 A MX2022010079 A MX 2022010079A MX 2022010079 A MX2022010079 A MX 2022010079A MX 2022010079 A MX2022010079 A MX 2022010079A MX 2022010079 A MX2022010079 A MX 2022010079A
Authority
MX
Mexico
Prior art keywords
sup
sub
compound
integer
formula
Prior art date
Application number
MX2022010079A
Other languages
English (en)
Inventor
Christopher M Cimarusti
Anandkumar Madanlal Lahoti
Madan Raja Gopal Reddy Daram
Original Assignee
Ayala Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayala Pharmaceuticals Inc filed Critical Ayala Pharmaceuticals Inc
Publication of MX2022010079A publication Critical patent/MX2022010079A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona métodos para preparar compuestos de Fórmula (I), en donde los compuestos están representados por la estructura de fórmula (I): (ver Fórmula) Fórmula (I) en donde: cada uno de R1 es independientemente F, Cl, Br, I, OCH3, CN o NO2; cada uno de R2 es independientemente alquilo C1-C5 idéntico o diferente; n1 es un número entero entre 1 y 5; y n2 es un número entero entre 1 y 4. Además, la presente invención proporciona un compuesto representado por las siguientes estructuras: (ver Fórmulas) en donde X comprende: cloruro, acetato, adipato, alginato, ascorbato, aspartato, benzoato, bencenosulfonato, bisulfato, borato, butirato, citrato, alcanforato, alcanforsulfonato, ciclopentanopropionato, digluconato, dodecilsulfato, etanosulfonato, fumarato, glucoheptanoato, glicerofosfato, hemisulfato, heptanoato, hexanoato, yodhidrato, maleato, 2-hidroxietanosulfonato, lactato, metanosulfonato, 2-naftalenosulfonato, nicotinato, nitrato, oxalato, pectinato, persulfato, 3-fenilpropionato, fosfato, picrato, pivalato, propionato, salicilato, succinato, sulfato, sulfonato, tartrato, tiocianato, sal de toluenosulfonato o sal de undecanoato, o cualquier combinación de los mismos.
MX2022010079A 2020-02-16 2021-02-16 Metodos para preparar derivados quirales de benzodiazepinona. MX2022010079A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062977316P 2020-02-16 2020-02-16
PCT/US2021/018137 WO2021163676A1 (en) 2020-02-16 2021-02-16 Methods of preparing chiral benzodiazepinone derivatives

Publications (1)

Publication Number Publication Date
MX2022010079A true MX2022010079A (es) 2022-09-02

Family

ID=77291712

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010079A MX2022010079A (es) 2020-02-16 2021-02-16 Metodos para preparar derivados quirales de benzodiazepinona.

Country Status (11)

Country Link
US (1) US20230108536A1 (es)
EP (1) EP4107148A4 (es)
JP (1) JP2023513731A (es)
KR (1) KR20220143094A (es)
CN (1) CN115103836A (es)
AU (1) AU2021218456A1 (es)
BR (1) BR112022016249A2 (es)
CA (1) CA3171651A1 (es)
IL (1) IL295572A (es)
MX (1) MX2022010079A (es)
WO (1) WO2021163676A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010073253A1 (en) * 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
TWI614238B (zh) * 2012-09-21 2018-02-11 必治妥美雅史谷比公司 雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
CN105308030A (zh) * 2012-09-21 2016-02-03 百时美施贵宝公司 烷基、氟烷基-1,4-苯并二氮杂*酮化合物
EP2897954B1 (en) * 2012-09-21 2016-10-26 Bristol-Myers Squibb Company Fluoroalkyl-1,4-benzodiazepinone compounds
WO2014047397A1 (en) * 2012-09-21 2014-03-27 Bristol-Myers Squibb Company Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch|inhibitors
US10479763B2 (en) * 2015-02-17 2019-11-19 Amorepacific Corporation Chiral resolution method of N-[4-(1-aminoethyl)-phenyl]-sulfonamide derivatives
CN105439939B (zh) * 2015-11-12 2018-12-04 四川恒康科技发展有限公司 一种(S)-N-Boc-3-羟基哌啶的合成方法

Also Published As

Publication number Publication date
WO2021163676A1 (en) 2021-08-19
JP2023513731A (ja) 2023-04-03
AU2021218456A1 (en) 2022-09-22
EP4107148A1 (en) 2022-12-28
KR20220143094A (ko) 2022-10-24
EP4107148A4 (en) 2024-05-15
CA3171651A1 (en) 2021-08-19
CN115103836A (zh) 2022-09-23
US20230108536A1 (en) 2023-04-06
IL295572A (en) 2022-10-01
BR112022016249A2 (pt) 2022-10-11

Similar Documents

Publication Publication Date Title
EP0945440A4 (en) AMINOPYRAZOLE DERIVATIVES
ES2118160T3 (es) Compuestos de azol, su produccion y su uso.
CA2319005A1 (en) 2-pyridylmethylamine derivatives useful as fungicides
ES2094218T3 (es) Derivados de 2-nitroimidazol, su fabricacion, y agente radiosensibilizante que lo incluye como principio activo.
HK1107814A1 (en) Thiadiazoline derivatives for treating cancer
AR054831A1 (es) Derivados de heptaazafenaleno, procedimientos para su obtencion, asi como utilizacion de los mismos como agentes protectores contra la radiacion uv
MX2022010079A (es) Metodos para preparar derivados quirales de benzodiazepinona.
KR950008508A (ko) 아졸 화합물, 그의 제법 및 용도
EP0945439A4 (en) NEW AMINOPYRAZOLE DERIVATIVES
ATE205072T1 (de) Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung
DE3362241D1 (de) Antifungal triazolyl propanol derivatives
WO2000036061A3 (de) Teilchenförmig konfektionierte acetonitril-derivate als bleichaktivatoren in festen reinigungsmitteln
ES2249636T3 (es) Triazoles como antagonistas de la oxitocina.
IL70718A0 (en) Triazole derivatives,their preparation and pharmaceutical compositions containing them
KR920008028A (ko) 피리딘 유도체, 이의 제조방법 및 용도
SU1676436A3 (ru) Способ борьбы с грибковыми инфекци ми
EP0995437A4 (en) 2,3-DIHYDROBENZOFURAN DERIVATIVES
KR930023031A (ko) 아졸 유도체를 함유하는 항아로마타제제
ES2172799T3 (es) Concentrado liquido de almidon para el lavado.
ES2073922T3 (es) Procedimiento para mejorar la eficacia terapeutica de agentes antifungicos liposolubles de la familia de los imidazoles y composicion para la realizacion de este procedimiento.
ECSP034690A (es) Mezclas fungicidas a base de compuestos de amida
GB1064311A (en) Phosphorus-containing derivatives of 6-chromanol
IL40218A (en) 1,2,4-thiadiazole derivatives,their preparation and their use as biocides
GB979389A (en) Pharmaceutical compositions containing naphthalene derivatives
ES8301260A1 (es) Procedimiento para preparar derivados de estilbeno